SEC Form 4 · accession 0001131096-16-000230
ATHENAHEALTH INC · ATHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ed Park
Officer — EVP and COO
Period of report
Jan 6, 2016
Accepted (ET)
Jan 8, 2016 · 7:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131096
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 6, 2016 | S | 600 | $160.75 | D | 29,833 | D | |
| Common StockF1,F3 | Jan 6, 2016 | S | 340 | $161.69 | D | 29,493 | D | |
| Common StockF1,F4 | Jan 6, 2016 | S | 500 | $163.11 | D | 28,993 | D | |
| Common StockF1 | Jan 6, 2016 | S | 60 | $164.20 | D | 28,933 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 30, 2015, in accordance with Rule 10b5-1.
- F2This price represents the weighted average of sales ranging from $160.41 to $161.37. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average of sales ranging from $161.41 to $161.83. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F4This price represents the weighted average of sales ranging from $162.72 to $163.57. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.